Synthesis and Activity of C 11-Modified Wortmannin Probes for PI 3 Kinase

The key role played by PI3 kinase in cancer, hormone action, and a host of other biological functions suggests that specific inhibitors whose disposition could be ascertained in vivo would be useful in biological research or, potentially, for imaging PI3K in a clinical setting. Wortmannin (Wm, 1) is an inhibitor of PI3 kinase with high specificity for this enzyme. We synthesized three modified Wm probes, a biotinylated Wm (7a), a 4-hydroxy-3-iodophenylated Wm, which was obtained both unlabeled (7b) and labeled with 125I (8), and a fluoresceinated Wm (7c), through modification at C-11, and evaluated their inhibitive activity as inhibitors of PI3 kinase. Biotinylated (7a) and 4-hydroxy-3-iodophenylated Wm’s (7b) had IC50s for PI3K of 6.11 and 11.02 nM, respectively, compared to an IC50 for Wm of 1.63 nM. Fluoresceinated Wm (7c) lost considerably more activity than the other derivatives, with an IC50 of 64.9 nM. The 125I labeled 4-hydroxy-3-iodophenylated Wm (8) could be detected after reaction with an immunoprecipitate of PI3 kinase. The activity of these reporter Wm’s is discussed in relationship to earlier findings on the pharmacological activity of Wm derivatives and the ability of inhibitors to fit into the ATP pocket of PI3 kinase.

[1]  P. Koty,et al.  Detection of programmed cell death in cells exposed to genotoxic agents using a caspase activation assay. , 2005, Methods in molecular biology.

[2]  S. Eccles,et al.  Phosphoinositide 3-Kinase Signalling Pathways in Tumor Progression, Invasion and Angiogenesis , 2004, Tumori.

[3]  Sanjai Kumar,et al.  Activity-based probes for protein tyrosine phosphatases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Zuhowski,et al.  Use of high-performance liquid chromatography to characterize the rapid decomposition of wortmannin in tissue culture media. , 2003, Analytical Biochemistry.

[5]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[6]  M. Habeck.  Knocking down the PI3 kinase pathway , 2003 .

[7]  Yann Seimbille,et al.  18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals , 2002, Steroids.

[8]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[9]  L. Cantley,et al.  Phosphoinositide 3-kinase in immunological systems. , 2002, Seminars in immunology.

[10]  S. Okarvi,et al.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals , 2001, European Journal of Nuclear Medicine.

[11]  Roger L. Williams,et al.  Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. , 2000, Molecular cell.

[12]  P. Taylor,et al.  Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase. , 2000, Bioorganic & medicinal chemistry letters.

[13]  A. Hermetter,et al.  Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. , 1999, Atherosclerosis.

[14]  F. Alt,et al.  Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.

[15]  R. Schultz,et al.  Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. , 1996, Journal of medicinal chemistry.

[16]  J. Dodge,et al.  Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. , 1996, Journal of medicinal chemistry.

[17]  J. Melrose,et al.  Biotinylated aprotinin: a versatile probe for the detection of serine proteinases on western blots. , 1995, The international journal of biochemistry & cell biology.

[18]  O. Hazeki,et al.  Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. , 1995, Trends in biochemical sciences.

[19]  S. Nakanishi,et al.  Novel functions of phosphatidylinositol 3-kinase in terminally differentiated cells. , 1995, Cellular signalling.

[20]  C. Honer,et al.  The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. , 1995, Cellular signalling.

[21]  T. Okada,et al.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.

[22]  M. Welch,et al.  Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors. , 1993, Journal of medicinal chemistry.